MedTrace Logo

Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury

NCT01225055 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-02

Study results available
· View outcomes & findings →

Summary

Spinal cord injury (SCI) results in marked acute loss of bone. This study evaluates the effect of teriparatide (PTH) and the use of vibration as a form of mechanical stimulation on bone mass.

Conditions

Interventions

DRUG

Teriparatide

20 ug daily over 12 months

DEVICE

vibration

10 min/day for 12 months

Sponsors & Collaborators

  • Edward Hines Jr. VA Hospital

    collaborator FED

  • University of Illinois at Chicago

    collaborator OTHER

  • Congressionally Directed Medical Research Program

    collaborator UNKNOWN

  • Thomas J. Schnitzer

    lead OTHER

Principal Investigators

  • Thomas J Schnizter, MD, PhD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2015-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01225055 on ClinicalTrials.gov